NCT06269822

Brief Summary

The study aimed at detection of autonomic dysfunction among cases with temporal lobe epilepsy; using different electrophysiological techniques. Moreover, it aimed at finding any correlation between electrophysiological tests and SUDEP risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 10, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

1.2 years

First QC Date

February 10, 2024

Last Update Submit

February 17, 2024

Conditions

Keywords

Temporal Lobe epilepsy (TLE)Sudden unexpected death of epileptic patients (SUDEP)DysautonomiaQuantitative EEG (QEEG)Sympathetic Skin Response (SSR)Heart Rate Variability (HRV)

Outcome Measures

Primary Outcomes (2)

  • Detection of autonomic dysfunction (sympathetic domain) among cases of temporal lobe epilepsy

    Assessing the sympathetic domain of the autonomic nervous system using sympathetic skin response (SSR) test; in which response latency and amplitude were measured and then compared to the matched controls (higher amplitude signifying higher sympathetic tone)

    30 minutes was the estimated test time. Outcome was assessed through study completion

  • Detection of autonomic dysfunction (Para-sympathetic domain) among cases of temporal lobe epilepsy

    Evaluating the parasympathetic domain of the ANS using the heart rate variability test(HRV); in which root mean square of successive differences (RMSSD) as a time domain parameter was measured and then compared to the matched controls ( Reduced RMSSD denoting reduced vagal tone)

    20 minutes was the estimated test time. Outcome was assessed through study completion

Secondary Outcomes (1)

  • Detection of the sudden unexpected death of epileptic patient (SUDEP) risk using Quantitative EEG (QEEG) in temporal lobe epilepsy(TLE) patients

    30-45 minutes is the estimated test time. Outcome was assessed through study completion

Study Arms (2)

Cases

Group-1: Patients with TLE of both genders and aged \> 18 years old

Diagnostic Test: Sympathetic skin response, heart rate variability test, quantitative EEG

Controls

Group-2: Age/gender matched healthy controls

Diagnostic Test: Sympathetic skin response, heart rate variability test, quantitative EEG

Interventions

Sympathetic skin test (electrodermal activity) to test for sympathetic function Heart rate variability test to assess cardiovagal function Quantitative EEG to quantitatively assessing the brain function using fast fourier transform technique

CasesControls

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Out-patient epilepsy clinic at kasr alainy hopsital -Cairo University

You may qualify if:

  • Patients diagnosed as temporal lobe epilepsy(TLE) depending on clinical semiology and EEG temporal inter-ictal epileptiform discharges

You may not qualify if:

  • Any identifiable disease that could affect autonomic nervous system function including diabetic patients.
  • Any drug that could affect autonomic nervous system function including oral contraceptives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Neurophysiology unit- Kasr alainy-Cairo University

Cairo, Cairo Governorate, Cairo, Egypt, Egypt

Location

Related Publications (3)

  • Clemens B, Emri M, Fekete I, Fekete K. Epileptic diathesis: An EEG-LORETA study. Clin Neurophysiol. 2023 Jan;145:54-61. doi: 10.1016/j.clinph.2022.11.004. Epub 2022 Nov 17.

    PMID: 36442376BACKGROUND
  • Barot N, Nei M. Autonomic aspects of sudden unexpected death in epilepsy (SUDEP). Clin Auton Res. 2019 Apr;29(2):151-160. doi: 10.1007/s10286-018-0576-1. Epub 2018 Nov 19.

    PMID: 30456432BACKGROUND
  • Vieluf S, El Atrache R, Hammond S, Touserkani FM, Loddenkemper T, Reinsberger C. Peripheral multimodal monitoring of ANS changes related to epilepsy. Epilepsy Behav. 2019 Jul;96:69-79. doi: 10.1016/j.yebeh.2019.02.018. Epub 2019 May 14.

    PMID: 31100658BACKGROUND

MeSH Terms

Conditions

Epilepsy, Temporal LobeAutonomic Nervous System Diseases

Condition Hierarchy (Ancestors)

Epilepsies, PartialEpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEpileptic Syndromes

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

February 10, 2024

First Posted

February 21, 2024

Study Start

September 1, 2022

Primary Completion

November 25, 2023

Study Completion

January 1, 2024

Last Updated

February 21, 2024

Record last verified: 2024-02

Locations